Form D · Other Technology
Vero Labs, Inc.
New York, NY · CIK 0001623045
Offering snapshot reported Oct 30, 2014 · SEC filing
- Reported sold
- $6 Offering amount: $6
- Investors reported
- 19 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 15, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 30, 2014 | Initial | $6 | No comparison | 19 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 04
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-227399
Source: Form D, filed Oct 30, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Scott Birnbaum | Executive |
| Ayman Hariri | Director, Executive |
| Motaz Nabulsi | Executive |
Issuer details
Industry: Other Technology (See others in industry)
Address:
9 East 8 Th Street Suite 270
New York, NY, 10003
New York, NY, 10003